High Risk of Graft Rejection in Patients with HLA Homozygosity Following Haploidentical Transplant Using Post-Transplant Cyclophosphamide. - Jindal N; Patel K; Garg M; Mirgh S; Chichra A; Nayak L; Gokarn A; Punatar S; Bagal B; Mathew LJ; D'Silva S; Singh M; et al. (Blood cell therapy, 2025)